PubRank

A Hatzakis

Author PubWeight™ 105.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996 4.05
2 Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996 3.50
3 Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995 2.74
4 HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill 2011 2.42
5 Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill 2009 1.98
6 Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 1991 1.91
7 Short-term effects of air pollution on mortality in Athens. Int J Epidemiol 1986 1.61
8 Increased liver decompensation risk with atypical hepatitis C virus antibody levels. J Infect Dis 2000 1.41
9 Air pollution and cause specific mortality in Athens. J Epidemiol Community Health 1990 1.38
10 A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction 1998 1.30
11 Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004 1.28
12 Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. The Multicenter Hemophilia Cohort Study. J Infect Dis 1999 1.27
13 School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study. Euro Surveill 2009 1.24
14 Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat 2015 1.22
15 Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. J Virol Methods 2002 1.20
16 Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991 1.20
17 Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 1996 1.18
18 Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs. J Infect Dis 1988 1.15
19 The validity of gynecological ultrasonography. Gynecol Obstet Invest 1990 1.12
20 Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 2006 1.08
21 Effects of lead on the somatic growth of children. Arch Environ Health 1998 1.06
22 Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 1998 1.04
23 Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 1990 1.03
24 Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 1996 1.02
25 A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect 2008 1.02
26 Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments. J Viral Hepat 2005 0.98
27 Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection. J Infect Dis 2001 0.98
28 Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol 1995 0.98
29 Passive smoking and chronic obstructive lung disease. Lancet 1987 0.97
30 HIV epidemiology in Greece. Future Microbiol 2008 0.96
31 Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study. AIDS 1998 0.96
32 Incidence of lymphomas and other cancers in HIV-infected and HIV-uninfected patients with hemophilia. JAMA 1992 0.95
33 The epidemiologic profile of Kaposi's sarcoma in Greece prior to and during the AIDS era. Int J Cancer 1997 0.95
34 Searching for West Nile virus (WNV) in Greece. Transfus Med 2009 0.95
35 Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology. J Clin Microbiol 2009 0.95
36 Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol 2001 0.94
37 Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection. J Viral Hepat 2004 0.94
38 SlidingBayes: exploring recombination using a sliding window approach based on Bayesian phylogenetic inference. Bioinformatics 2004 0.93
39 Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1996 0.93
40 Time trends of tobacco smoking, air pollution, and lung cancer in Athens. Environ Res 1987 0.92
41 The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer 1999 0.91
42 Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Virol Methods 2001 0.90
43 Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2. J Viral Hepat 2015 0.89
44 Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies. Euro Surveill 2009 0.89
45 Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group. J Infect Dis 1993 0.87
46 Prevalence patterns and genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. J Med Virol 1998 0.86
47 Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. Liver Transpl Surg 1999 0.86
48 Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: a 5-year prospective study. Gastroenterology 1992 0.86
49 Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999 0.86
50 Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. Liver 2001 0.86
51 Unusual CD4+CD8+ phenotype in a greek patient diagnosed with adult T-cell leukemia positive for human T-cell leukemia virus type I (HTLV-I). Leuk Res 2000 0.86
52 Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases. Scand J Infect Dis 1996 0.86
53 Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C. Aliment Pharmacol Ther 2006 0.86
54 Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. AIDS Res Hum Retroviruses 1999 0.86
55 Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D. J Viral Hepat 2012 0.85
56 Significance of IgM anti-HCV core level in chronic hepatitis C. J Hepatol 1997 0.84
57 Re-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern. J Gen Virol 2001 0.83
58 Exposure to lead and cadmium of children living near a lead smelter at Lavrion, Greece. Sci Total Environ 1989 0.83
59 The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic. Euro Surveill 2010 0.83
60 Factors associated with severity and disease progression in chronic hepatitis C. Hepatogastroenterology 1999 0.83
61 Comparative hepatitis A seroepidemiology in 10 European countries. Epidemiol Infect 2012 0.83
62 Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis. J Viral Hepat 2013 0.82
63 Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile. Int J Dermatol 1997 0.82
64 T cell receptor excision circles and HIV-1 2-LTR episomal DNA to predict AIDS in patients not receiving effective therapy. AIDS 2001 0.82
65 Molecular epidemiology of vertical human immunodeficiency virus type 1 transmission in Greece: evidence of non-B subtypes. J Hum Virol 2000 0.82
66 The effect of involuntary smoking on the occurrence of chronic obstructive pulmonary disease. Soz Praventivmed 1990 0.82
67 Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece. Virus Res 2005 0.82
68 Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Vox Sang 2007 0.82
69 Delta agent and the etiology of hepatocellular carcinoma. Int J Cancer 1987 0.81
70 Differential diagnosis of acute HBsAg positive hepatitis using IgM anti-HBc by a rapid, fully automated microparticle enzyme immunoassay. J Hepatol 1997 0.81
71 Infectious disease control in the Ionian Islands during the British Protection (1815-1864). J R Army Med Corps 2013 0.81
72 Hepatitis C virus infection among Greek renal transplant patients. Gut 1993 0.81
73 Failure to detect human papillomavirus in Kaposi's sarcoma. Lancet 1992 0.80
74 Re-analysis of 34 full-length HIV-1 intersubtype recombinant sequences. Infect Genet Evol 2004 0.80
75 Estimating the treatment cascade of chronic hepatitis B and C in Greece using a telephone survey. J Viral Hepat 2014 0.80
76 Case report: role of hepatitis E virus in the etiology of community-acquired non-A, non-B hepatitis in Greece. J Med Virol 1994 0.80
77 Analysing the evolutionary history of HCV: puzzle of ancient phylogenetic discordance. Infect Genet Evol 2006 0.80
78 Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA. J Clin Microbiol 2009 0.79
79 Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1998 0.79
80 Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions. J Med Virol 2004 0.79
81 Concurrent hepatitis B, delta and human immunodeficiency virus infection in hemophiliacs. Thromb Haemost 1987 0.79
82 Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): unidentified regions may be derived from parental subtype E sequences. AIDS Res Hum Retroviruses 2000 0.79
83 Seroepidemiology of human herpesvirus 8 (HHV-8) infection in injecting drug users. Epidemiol Infect 2009 0.79
84 Prevalence and genotypic distribution of TT virus in Athens, Greece. J Med Virol 2001 0.79
85 Molecular epidemiology of HPV infection using a clinical array methodology in 2952 women in Greece. Clin Microbiol Infect 2011 0.78
86 Sex-related differences in immunoglobulin M and in total antibody response to hepatitis A virus observed in two epidemics of hepatitis A. Am J Epidemiol 1984 0.78
87 Significance of immune status, genotype and viral load in the severity of chronic hepatitis C in HIV infected haemophilia patients. Haemophilia 2002 0.78
88 Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999 0.78
89 Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients. AIDS 1999 0.78
90 Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients. Haemophilia 2005 0.77
91 A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C. J Viral Hepat 2003 0.77
92 Cost-effectiveness of hepatitis-B vaccine in Greece. A country of intermediate HBV endemicity. Int J Technol Assess Health Care 1991 0.77
93 Antiretrovirals for HIV Exposure Prophylaxis. Curr Med Chem 2012 0.77
94 Endemic hepatitis delta virus infection in a Greek community. Prog Clin Biol Res 1987 0.77
95 Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): evidence to support the existence of a novel HIV-1 subtype. J Gen Virol 2001 0.77
96 Comparison of smoothing techniques for CD4 data in a Markov model with states defined by CD4: an example on the estimation of the HIV incubation time distribution. Stat Med 2001 0.77
97 The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries. Epidemiol Infect 2008 0.77
98 Cholestatic syndromes in renal transplant recipients with HCV infection. Transpl Int 2000 0.77
99 Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial. Am J Gastroenterol 1996 0.77
100 Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece. Virus Res 2002 0.77
101 Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece. J Med Virol 2000 0.76
102 Renal transplantation from hepatitis B surface antigen (HBsAg)-positive donors to HBsAg-negative recipients: a case of post-transplant fulminant hepatitis associated with an extensively mutated hepatitis B virus strain and review of the current literature. Transpl Infect Dis 2013 0.76
103 Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers. Am J Gastroenterol 1995 0.75
104 Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis. Gut 1993 0.75
105 Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides. Cancer Res 1992 0.75
106 Antibodies against hepatitis C virus among renal transplant patients in Greece. Transpl Int 1992 0.75
107 The AIDS profile in a low risk country: the central role of bisexual men. J Epidemiol Biostat 2000 0.75
108 The phylogenetic information profile of HIV-1 and the degradation effect of recombination. Infect Genet Evol 2007 0.75
109 HIV/HBV co-infection and rate of antiretroviral treatment change after highly active antiretroviral treatment initiation in a cohort of HIV-infected patients in Greece. Int J STD AIDS 2010 0.75
110 Total and cause-specific mortality in a population based cohort of diabetics in Greece. Diabete Metab 1991 0.75
111 Histological and functional changes in the salivary glands in thalassaemia major. Haematologia (Budap) 1995 0.75
112 Neuropsychological assessment of HIV-seropositive haemophiliacs. AIDS 1991 0.75
113 Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis. Transfusion 1997 0.75
114 Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease. J Hepatol 1994 0.75
115 Opportunistic malignancies and the acquired immunodeficiency syndrome. Princess Takamatsu Symp 1987 0.75
116 Treatment of acute non-A, non-B hepatitis with interferon alpha-2b. Infection 1992 0.75
117 Natural history of HIV-1 infection. Clin Dermatol 2000 0.75
118 Successful virological outcome in an HIV-infected individual with a three-class resistant variant and an insertion in the protease genome with a Tipranavir based regimen. Ir J Med Sci 2008 0.75
119 Hepatitis B vaccine in haemodialysis patients. Lancet 1984 0.75
120 [Activity of the monooxygenase enzyme system in the liver of "healthy" HBsAg carriers]. Bratisl Lek Listy 1985 0.75
121 Detection of specific antibodies to HCV-ARF/CORE+1 protein in patients treated with pegylated interferon plus ribavirin. J Viral Hepat 2011 0.75
122 Allele frequency of the CCR5 mutant chemokine receptor in Greek Caucasians. J Acquir Immune Defic Syndr Hum Retrovirol 1998 0.75
123 A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1. J Viral Hepat 2003 0.75
124 Genotypic characterization of human immunodeficiency virus type 1 in Greece. Multicentre Study on HIV-1 Heterogeneity. AIDS Res Hum Retroviruses 1998 0.75
125 Prevalence of antibodies to hepatitis C virus in Greek patients with chronic liver disease. J Hepatol 1994 0.75
126 Peripheral occlusive arterial disease in longstanding diabetes mellitus. A population study. Int Angiol 1989 0.75
127 Biochemical and virological response of chronic hepatitis C after treatment with interferon-alpha for 6 or 12 months: predictors of sustained remission. Eur J Gastroenterol Hepatol 1996 0.75
128 The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus. J Viral Hepat 2007 0.75
129 Hepatitis B vaccination strategy for health-care workers in a country of intermediate hepatitis B endemicity. J Infect 1983 0.75
130 Virological and immunological response to HAART therapy in a community-based cohort of HIV-1-positive individuals. HIV Clin Trials 2001 0.75
131 Liver biopsy is essential in anti-HCV (+) renal transplant patients irrespective of liver function tests and serology for HCV. Transplant Proc 1995 0.75